Skip to content

A study to investigate the impact of chocolate intake on blood pressure

A study to investigate the impact of chocolate intake on blood pressure - A study to investigate the impact of chocolate intake on blood pressure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000032440
Enrollment
170
Registered
2018-05-06
Start date
2018-06-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subjects with high normal blood pressure and subjects with grade I hypertension

Interventions

Intake of chocolate (4 weeks). Intake of placebo chocolate (4 weeks).

Sponsors

CROee.INC
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Subjects who competent to consent and give voluntary consent in writing with full understanding after receiving explanation of this study aim and contents. 2) Subjects who are adults of both sexes above 40 years old- under 69 years old at the point of obtaining informed consent. 3) Subjects with high normal blood pressure or grade I hypertension at the point of screening(2) High normal blood pressure: Systolic BP from 130 to 139 mmHg and/ or diastolic blood pressure from 85 to 89 mm Hg Grade I hypertension : Systolic BP from 140 to 159 and/ or diastolic blood pressure from 90 to 99 mm Hg) 4) Subjects with BMI above 18.5 kg/ m2-under 30 kg/ m2 at the point of screening(1)

Exclusion criteria

Exclusion criteria: 1) Subjects who are under treatment for chronic disorders 2) Subjects who are in pregnancy, lactation, or who are willing to become pregnant during this study 3) Subjects who participated in other clinical trial or monitor study within 1 month prior to screening(1) 4) Subject with allergy to cacao, milk constituent and soy 5) Subjects with lactose intolerance 6) Subjects who highly intake cacao products on a daily basis 7) Subjects who intake medical chemicals, quasi-drugs, supplements, health foods, foods for specified health uses, foods with function claims that potentially influence the outcome of this study within 3 month prior to the screening(1) on regular basis or subjects who plan to intake these during this study 8) Subjects who is ineligible for this study due to principal investigator's judgment

Design outcomes

Primary

MeasureTime frame
Systolic blood pressure

Secondary

MeasureTime frame
Diastolic blood pressure HDL-cholesterol (HDL-C), LDL-cholesterol (LDL-C), hs-CRP Subjective evaluation questionnaire

Countries

Japan

Contacts

Public ContactShigeru Imai

CROee.INC Evidence Division

imai@croee.com03-5953-2108

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026